Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matcheri Keshavan

Showing results (211-220 of 255) with videos related to

Pageof 26
Sort By:
Frontiers in Psychiatry|May 8, 2023
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosisCarolyn M Amir, Simon Kapler, Gil D Hoftman, et al.
Psychiatry Research|March 4, 2022
Family history of psychosis in youth at clinical high risk: A replication studyOlga Santesteban-Echarri, Danah Sandel, Lu Liu, et al.
Schizophrenia Research|November 2, 2020
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcomeRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Schizophrenia Research|March 1, 2023
Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosisTimothy I Michaels, Ricardo E Carrión, Jean Addington, et al.
Schizophrenia Bulletin|March 21, 2026
The Utility of Negative Symptoms in Predicting Transition to Psychosis Among Individuals at Clinical High RiskMitchell D Arnovitz, Barbara A Cornblatt, Andrea M Auther, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 18, 2026
Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for PsychosisDaniel Bello, Jillian G Connolly, Jean Addington, et al.
Schizophrenia Research|August 28, 2022
Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosisOlga Santesteban-Echarri, Lu Liu, Madeline Miller, et al.
Schizophrenia Research|July 18, 2024
Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioningRicardo E Carrión, Benson S Ku, Sarah Dorvil, et al.
Schizophrenia Research|July 19, 2024
Sex differences in clinical presentation in youth at high risk for psychosis who transition to psychosisAraba Chintoh, Lu Liu, Amy Braun, et al.
Global Mental Health (Cambridge, England)|September 13, 2021
Cross cultural and global uses of a digital mental health app: results of focus groups with clinicians, patients and family members in India and the United StatesElena Rodriguez-Villa, Abhijit R Rozatkar, Mohit Kumar, et al.
Pageof 26

Showing results (211-220 of 255) with videos related to

Sort By:
Pageof 26
Frontiers in Psychiatry|May 8, 2023
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosisCarolyn M Amir, Simon Kapler, Gil D Hoftman, et al.
Psychiatry Research|March 4, 2022
Family history of psychosis in youth at clinical high risk: A replication studyOlga Santesteban-Echarri, Danah Sandel, Lu Liu, et al.
Schizophrenia Research|November 2, 2020
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcomeRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Schizophrenia Research|March 1, 2023
Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosisTimothy I Michaels, Ricardo E Carrión, Jean Addington, et al.
Schizophrenia Bulletin|March 21, 2026
The Utility of Negative Symptoms in Predicting Transition to Psychosis Among Individuals at Clinical High RiskMitchell D Arnovitz, Barbara A Cornblatt, Andrea M Auther, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 18, 2026
Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for PsychosisDaniel Bello, Jillian G Connolly, Jean Addington, et al.
Schizophrenia Research|August 28, 2022
Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosisOlga Santesteban-Echarri, Lu Liu, Madeline Miller, et al.
Schizophrenia Research|July 18, 2024
Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioningRicardo E Carrión, Benson S Ku, Sarah Dorvil, et al.
Schizophrenia Research|July 19, 2024
Sex differences in clinical presentation in youth at high risk for psychosis who transition to psychosisAraba Chintoh, Lu Liu, Amy Braun, et al.
Global Mental Health (Cambridge, England)|September 13, 2021
Cross cultural and global uses of a digital mental health app: results of focus groups with clinicians, patients and family members in India and the United StatesElena Rodriguez-Villa, Abhijit R Rozatkar, Mohit Kumar, et al.
Pageof 26